DelSiTech is an innovative drug delivery technology company that helps its customers to turn their active agents into novel and useful therapeutic drug products.DelSiTech also develops its own supergeneric drug products to address significant unmet medical and commercial needs.
DelSiTech provides the technology and expertise for solving drug delivery problems.
The company's technology is based on amorphous silica (SiO2) matrix and sol-gel encapsulation technique which have significant competitive advantages over other technologies.
Location: Finland, Southwest Finland, Turku
Employees: 11-50
Total raised: $10.87M
Founded date: 2001
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.01.2024 | - | $10.87M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 16.01.2024 | DelSiTech Closes EUR 10M Financing Round | DelSiTech, a Turku, Finland-based clinical-stage drug delivery and development company, raised EUR 1... | finsmes.co... |
| 20.03.2023 | Finnish pharma company DelSiTech is awarded a grant from the... | Finnish pharma company DelSiTech is awarded a grant from the Bill & Melinda Gates Foundation 20... | ain.capita... |
| 18.05.2022 | DelSiTech and Anticancer Bioscience Announce a Collaboration... | TURKU, Finland, May 18, 2022 /PRNewswire/ -- DelSiTech Ltd, the leading silica drug delivery technol... | en.prnasia... |
| 24.10.2018 | DelSiTech Receives Funding from Bill & Melinda Gates Fou... | DelSiTech Ltd, a Turku, Finland-based drug delivery and drug development company, received grant fun... | finsmes.co... |
| - | DelSiTech: Clinical-Stage Drug Delivery Company Raises €10 M... | Clinical-stage drug delivery and development company DelSiTech recently announced the successful com... | pulse2.com... |